echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > An innovative NRF2 nanomodulator induces iron death of lung cancer and induces immune-stimulated tumor microenvironment

    An innovative NRF2 nanomodulator induces iron death of lung cancer and induces immune-stimulated tumor microenvironment

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A nano- drug targeting both the tumor microenvironment and cancer cells has not been reported so far


    Nano Tumor Nano (ZVI-NP) Tumor is a dual-functional nanomedicine that establishes an effective strategy for synergistically inducing iron chain cancer cell death and reprogramming the immunosuppressive microenvironment, which highlights ZVI-NP as an advanced comprehensive anti-cancer strategy Potential



    Image source: doi:10.


    doi:10.


    Zero-valent iron nanoparticles (Zvi) are widely used in the treatment of groundwater or wastewater containing a variety of organic and inorganic pollutants due to their strong reduction ability and wide availability


    (Zvi) ZVI-NP Fenton (ROS) Tumor (TME) ZVI-NP(ZVI@Ag) ZVI-NP ROS ZVI-NP(ZVI@CMC) ZVI-NP ZVI-NP Tumor

    Iron death is a new type of programmed cell death discovered in recent years


    Iron death is a new type of programmed cell death discovered in recent years


    Cancer immunotherapy, by enhancing the patient's own immune system to eliminate cancer cells, has completely changed the pattern of cancer treatment in the past decade


    Cancer immunotherapy, by enhancing the patient's own immune system to eliminate cancer cells, has completely changed the pattern of cancer treatment in the past decade




    ZVI-NPs

    Image source: doi: 10.


    doi: 10.


    In conclusion, this study determined the dual anti-cancer mechanism of ZVI-NP on non-malignant cells


    This study determined the dual anti-cancer mechanism of ZVI-NP on non-malignant cells


    Chih-Hsiung Hsieh et al.
    An innovative NRF2nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatorytumor microenvironment.
    Theranostics.
    2021; 11(14): 7072-7091.
    doi:10.
    7150/thno.
    57803

    Chih-Hsiung Hsieh et al.
    An innovative NRF2nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatorytumor microenvironment.
    Theranostics.
    2021; 11(14): 7072-7091.
    doi:10.
    7150/thno.
    57803

    Chih-Hsiung Hsieh et al.
    An innovative NRF2nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatorytumor microenvironment.
    Theranostics.
    2021; 11(14): 7072-7091.
    doi:10.
    7150/thno.
    57803

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.